Clinical trial
Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
NCT02804373 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- June 18, 2019
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.